Invited Speakers

Conference details

Invited Speakers

Fliser Danilo
Floege Juergen
Stevens Paul
Bakris George
Praga Manuel
Haynes Richard
Ronco Claudio
Combe Christian
Karras Alexander
Wanner Christoph
Kaxiras Efthimios
Gkrania Effrossyni
Fliser Danilo
Floege Juergen
Stevens Paul
Bakris George
Praga Manuel
Haynes Richard
Ronco Claudio
Combe Christian
Karras Alexander
Wanner Christoph
Kaxiras Efthimios
Gkrania Effrossyni

Dr Paul E. Stevens, MB, FRCP, RCPathME

Paul Stevens trained in Nephrology in the Royal Air Force and at The Charing Cross Hospital in London and was appointed as Consultant Physician and Nephrologist to the Royal Air Force in 1990. He returned to the NHS in April 1995 as Clinical Director of the Kent Kidney Care Centre, implementing a program of modernization and development and establishing a predominantly clinical research program in kidney disease. He has served on several national and college committees, is a former President of the British Renal Society, and was an advisor to the Department of Health for kidney disease and national implementation of eGFR reporting. His interest in guideline development began with commissioning guidance for the development of kidney services and the first UK CKD guideline in 2005. He served as clinical advisor and chair to several of the UK National Institute for Health and Care Excellence (NICE) Clinical Guidelines and chaired the NICE CKD topic expert reference group and the production of NICE Quality Standards in CKD. He is the current treasurer of the Kidney Disease: Improving Global Outcomes (KDIGO) Executive Committee and was privileged to have co-chaired both the KDIGO 2012 and 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.

George L. Bakris, MD, F.A.H.A., F.A.S.N.

Dr. Bakris is a Nephrologist/Certified Hypertension Specialist trained at the Mayo Clinic and the University of Chicago Medicine. He is a Professor of Medicine and Director of the Am. Heart Assoc. Comprehensive Hypertension Center at the University of Chicago Medicine. He has published over 1,000 peer-reviewed articles and edited or co-Editor 24 books in the areas of Diabetic Kidney Disease Progression and Hypertension. He is also the Senior Editor of the 3rd and new 4 edition of Hypertension: A Companion to Braunwald’s: The Heart. He has served on the Cardiorenal Advisory Board of the FDA and was a consultant to CMS. He has also served on many national guideline committees, including The Joint National Committee JNC 7 executive committee, and writing group, the American Diabetes Association (ADA) Clinical Practice Guideline Committee, and the National Kidney Foundation (K-DOQI), Blood Pressure and Diabetes Guideline committees. He Chaired the 2017 ADA Blood Pressure Consensus Report and served on the ACC/AHA writing committee on the Resistant Hypertension Consensus report (2018). He is also the senior author on the recent ADA/KDIGO Consensus Report for approaches to diabetic kidney disease (2022). Dr. Bakris is the past president of the American College of Clinical Pharmacology and the American Society of Hypertension (ASH). He is the recipient of the Irvine Page-Alva Bradley Lifetime Achievement Award-Am Heart Assoc. BP Council (2019), Lifetime Service Award of National Kidney Foundation of Illinois (2020) and the Lifetime Achievement Luminary Award in Cardiometabolic Med. by Heart and Diabetes Group (2023). He serves on numerous editorial boards and is the current Editor-in-Chief of Am J Nephrology, and Editor, UpToDate, Nephrology section, Hypertension Section, and Ad -Hoc Editor of Diabetes Care and Assoc Ed. Am. Heart J. Plus.

Manuel Praga MD, PhD

Manuel Praga MD, PhD, is Professor of Medicine at the Complutense University in Madrid, Spain. Dr Praga is a founding member and coordinator of the Group for the Study of Glomerular Diseases of the Spanish Society of Nephrology (GLOSEN). He has authored more than 425 peer-reviewed publications and numerous book chapters and has received many awards, including the “Iñigo Alvarez de Toledo” award to Clinical Investigation in 2000, 2008, 2011, 2016 and 2021. His current research activities focus on primary and secondary glomerular diseases, renal complications of obesity, diabetic nephropathy, progression of chronic kidney disease and interstitial nephritis.

CTM International SΑ 
Λεωφ. Βασ. Σοφίας 131, 115 21 Αθήνα
Τηλ: 210 3244932 – Fax: 210 3250660
Email: info@25psn.gr  Website: www.ctmi.gr

CTM International SΑ 
131 Vas. Sofias Ave., 115 21 Athens
Tel: 210 3244932 – Fax: 210 3250660
Email: info@25psn.gr  Website: www.ctmi.gr